Brazilian review explores emerging therapies for advanced Hodgkin lymphoma
A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, "Current perspectives on the management ...
Tag: Brentuximab Vedotin
SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma
A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial ...
Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma
A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to ...
